ReviewFrontiers in immunology2026
Animal models of antiphospholipid syndrome.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The role of neutrophil extracellular traps in antiphospholipid syndrome.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antiphospholipid syndrome (APS) is an autoimmune disorder defined by persistent antiphospholipid antibodies (aPL), thrombosis, and/or pathological pregnancy. Its phenotypic spectrum is heterogeneous and its pathogenesis remains incompletely understood. The incidence of APS increases year by year. Due to the constraints on human studies, animal models have become indispensable tools for dissecting the mechanisms of APS. The animal models accelerate the drug discovery and refine the therapeutic strategies in APS. Over the past decades, substantial methodological and translational advances have been achieved in APS animal models. In this review, we systematically summarize the current construction paradigms in thrombotic and obstetric APS animal models and highlight their respective advantages and limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.